SLC2A1 and central nervous system cancer: Compared to the non-modified nanoparticles, the uptake of DGlu-NP on RG-2 cells (a rat glioma cell line) was significantly increased, and could be inhibited by free glucose, suggesting that DGlu-NP was recognized by GLUT1 for enhanced cellular uptake.